VAXX — Vaxxinity Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Vaxxinity Announces Board Appointments And Establishes New Headquarters In Florida
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Blackstone, Ford
Brief: Vaxxinity Completes Enrollment In Phase 3 Trial Of UB-612 Covid-19 Vaccine
Brief: Vaxxinity Doses First Subjects In Phase 1 Clinical Trial Of UB-313
Brief: Vaxxinity Initiates Rolling Submission For Ub-612 Covid-19 Vaccine With MHRA(UK)
Brief: Vaxxinity Reports Second Quarter 2022 Financial Results And Provides Corporate Updates
Vaxxinity rises on smaller quarterly loss
Brief: Vaxxinity Reports First Quarter 2022 Financial Results
NASDAQ RESUMED AT 10:04 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:52 AM
Brief: Vaxxinity Receives FDA Fast Track Designation For Ub-311 For Treatment Of Alzheimer's Disease
NASDAQ RESUMED AT 12:10 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:05 PM
NASDAQ RESUMED AT 11:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:44 AM
NASDAQ RESUMED AT 11:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:32 AM
Brief: Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease
Fund Vaxxinity’S Pivotal Phase 3 Ub-612 Heterologous Booster Trial To Combat Sars-Cov-2 Variants